Correlation between CH2DS2-VASc Score and Serum Leptin Levels in Cardioembolic Stroke Patients: The Impact of Metabolic Syndrome
Objective. To determine adipokines levels in patients with different etiologic subtypes of acute ischemic stroke (AIS) and metabolic syndrome (MetS) status. Methods. Serum adiponectin, leptin, and resistin levels were determined by ELISA in 99 AIS patients and 59 stroke-free control group subjects....
Main Authors: | Anna Szczepańska-Szerej, Jacek Kurzepa, Aneta Grabarska, Joanna Bielewicz, Ewa Wlizło-Dyś, Konrad Rejdak |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2017/7503763 |
Similar Items
-
CHADS2 and CHA2DS2VASc scores as predictors of cardioembolic sources in secondary stroke prevention
by: Tiago Sá, et al.
Published: (2013-05-01) -
Clinical and biochemical predictors of late-outcome in patients after ischemic stroke
by: Joanna Ewa Bielewicz, et al.
Published: (2020-06-01) -
CHA2DS2-VASc and R2-CHA2DS2-VASc scores predict in-hospital and post-discharge outcome in patients with myocardial infarction
by: Michał Węgiel, et al.
Published: (2018-12-01) -
Prediction of coronary artery disease severity using CHADS2, CHA2DS2-VASC scores and a newly defined CHA2DS2-VASC-HS and CHA2DS2-VASC-HSF scores
by: Ranjan Modi, et al.
Published: (2014-11-01) -
Comparison of RCHA2DS2-VASc score and CHA2DS2-VASc score prediction of no-reflow phenomenon in patients with ST-segment elevation myocardial infarction
by: Çağrı Zorlu, et al.
Published: (2020-10-01)